Saladax Biomedical

NEW YORK (GenomeWeb News) – Saladax Biomedical on Thursday said that its Saladax Biomedical Laboratories division has received licenses from three states allowing it to provide its MyCare tests to clinicians in those states.

NEW YORK (GenomeWeb News) – Chinese pharmaceutical firm Fosun Pharma has made a $22.5 million investment into Saladax Biomedical, making it the largest shareholder in the assay development company.

NEW YORK (GenomeWeb News) – Saladax on Friday said that it has reached a distribution deal with Transmedic covering Saladax's MyCare oncology therapeutic dose management assays in Singapore and Hong Kong.

NEW YORK (GenomeWeb News) – Saladax Biomedical today said that it will offer its My5-FU assay as part of its MyCare service offering later this year after regaining marketing rights to the test from Myriad Genetics.

NEW YORK (GenomeWeb News) – Saladax Biomedical said this week that it plans to open a CLIA lab at its headquarters in Bethlehem, Pa. The firm has applied for approval from both the State of Pennsylvania and the federal government and is targeting a launch next year.

NEW YORK (GenomeWeb News) – Saladax Biomedical today announced Ilex Medical will exclusively distribute three of its tests in Israel.

NEW YORK (GenomeWeb News) – Saladax today said it has expanded its relationship with Bristol-Myers Squibb and entered into a Master Early Development Collaboration Agreement.

People in the News

NEW YORK (GenomeWeb News) – Mark Boguski, a faculty member at the Harvard Medical School and Beth Israel Deaconess Medical Center, has co-founded a new consulting company called Genome Health Solutions.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Saladax Biomedical said today that Eilaf Pharma will exclusively distribute the My5-FU diagnostic test in Egypt and the Middle East North African region.

Pages

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.